Published in Endocrinol Metab (Seoul) on August 04, 2015
Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia. Korean J Intern Med (2016) 0.82
Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors. Drug Des Devel Ther (2016) 0.80
Implication of hepatokines in metabolic disorders and cardiovascular diseases. BBA Clin (2016) 0.77
Elevated circulating irisin is associated with lower risk of insulin resistance: association and path analyses of obese Chinese adults. BMC Endocr Disord (2016) 0.76
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide. Gastroenterol Res Pract (2017) 0.75
Development of a high-throughput method for real-time assessment of cellular metabolism in intact long skeletal muscle fibre bundles. J Physiol (2016) 0.75
The Need for Standardized Assessment of Muscle Quality in Skeletal Muscle Function Deficit and Other Aging-Related Muscle Dysfunctions: A Symposium Report. Front Physiol (2017) 0.75
OPA1 deficiency promotes secretion of FGF21 from muscle that prevents obesity and insulin resistance. EMBO J (2017) 0.75
Low muscle mass is associated with cardiometabolic risk regardless of nutritional status in adolescents: A cross-sectional study in a Chilean birth cohort. Pediatr Diabetes (2017) 0.75
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11
TOR signaling in growth and metabolism. Cell (2006) 35.29
Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature (1997) 14.82
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature (2012) 14.67
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell (2004) 11.33
A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet (2006) 8.37
Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med (2004) 7.80
The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell (2004) 7.60
A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet (1997) 7.15
Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev (2004) 6.98
Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev (2006) 6.68
Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science (1994) 6.65
Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A (2001) 6.38
Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev (2001) 6.15
Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J (1994) 5.69
Smads: transcriptional activators of TGF-beta responses. Cell (1998) 5.33
Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985) (2000) 5.24
Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev (2008) 4.87
Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol (2012) 4.87
Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. J Clin Invest (2003) 4.79
Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J (2002) 4.75
Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res (1997) 4.74
A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med (1999) 4.61
Trends over 5 decades in U.S. occupation-related physical activity and their associations with obesity. PLoS One (2011) 4.21
Physical activity and breast cancer: a systematic review. Epidemiology (2007) 3.90
FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism (2012) 3.61
Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J (1995) 3.59
Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest (2002) 3.28
Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. JAMA (2003) 3.22
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol (2009) 3.18
Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil (2008) 3.13
Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab (2003) 2.90
Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes (2006) 2.80
Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab (2013) 2.64
IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab (2003) 2.59
Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running. J Physiol (1998) 2.49
Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metab (2013) 2.47
Mechanisms regulating skeletal muscle growth and atrophy. FEBS J (2013) 2.40
Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc (2004) 2.21
Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One (2010) 2.06
Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One (2009) 1.98
Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J (2001) 1.96
Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice. Diabetologia (2011) 1.85
Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology (1995) 1.85
A novel therapeutic approach to treating obesity through modulation of TGFβ signaling. Endocrinology (2012) 1.83
Effect of exercise training intensity on abdominal visceral fat and body composition. Med Sci Sports Exerc (2008) 1.69
Evidence against a beneficial effect of irisin in humans. PLoS One (2013) 1.68
Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Commun (2002) 1.63
Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil (2003) 1.60
The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans. FEBS J (2013) 1.58
Review of muscle wasting associated with chronic kidney disease. Am J Clin Nutr (2010) 1.55
Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3 beta pathway and is antagonized by insulin-like growth factor 1. J Biol Chem (2006) 1.55
Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle. Endocrinology (2008) 1.54
Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle. FASEB J (2013) 1.54
Pharmacological inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab (2014) 1.53
A deletion in the myostatin gene causes the compact (Cmpt) hypermuscular mutation in mice. Mamm Genome (1998) 1.52
Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes (2008) 1.51
Dynamics of the skeletal muscle secretome during myoblast differentiation. Mol Cell Proteomics (2010) 1.44
Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol Endocrinol (2006) 1.43
Signaling pathways controlling skeletal muscle mass. Crit Rev Biochem Mol Biol (2013) 1.43
Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Cytokine (2004) 1.42
Irisin - a myth rather than an exercise-inducible myokine. Sci Rep (2015) 1.39
The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity. Int J Obes (Lond) (2009) 1.34
Irisin and FNDC5 in retrospect: An exercise hormone or a transmembrane receptor? Adipocyte (2013) 1.32
Cytokine regulation of skeletal muscle fatty acid metabolism: effect of interleukin-6 and tumor necrosis factor-alpha. Am J Physiol Endocrinol Metab (2004) 1.32
Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol (2013) 1.32
Disuse-induced muscle wasting. Int J Biochem Cell Biol (2013) 1.32
Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses. J Appl Physiol (1985) (2004) 1.25
Fatty acid metabolism, energy expenditure and insulin resistance in muscle. J Endocrinol (2014) 1.25
Physical activity and inflammatory markers over 10 years: follow-up in men and women from the Whitehall II cohort study. Circulation (2012) 1.25
Association between interleukin-15 and obesity: interleukin-15 as a potential regulator of fat mass. J Clin Endocrinol Metab (2008) 1.24
IL-6 selectively stimulates fat metabolism in human skeletal muscle. Am J Physiol Endocrinol Metab (2010) 1.24
Irisin and exercise training in humans - results from a randomized controlled training trial. BMC Med (2013) 1.21
Exercise-induced AMPK activity in skeletal muscle: role in glucose uptake and insulin sensitivity. Mol Cell Endocrinol (2012) 1.20
Myostatin auto-regulates its expression by feedback loop through Smad7 dependent mechanism. J Cell Physiol (2006) 1.20
Clinical, agricultural, and evolutionary biology of myostatin: a comparative review. Endocr Rev (2008) 1.18
Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders. Exp Cell Res (2002) 1.16
A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers. Muscle Nerve (2012) 1.13
Effect of exercise, training, and glycogen availability on IL-6 receptor expression in human skeletal muscle. J Appl Physiol (1985) (2005) 1.12
IL-15 receptor deletion results in circadian changes of locomotor and metabolic activity. J Mol Neurosci (2009) 1.10
Computational reconstruction of the human skeletal muscle secretome. Proteins (2006) 1.09
Essential role of interleukin-15 receptor in normal anxiety behavior. Brain Behav Immun (2010) 1.09
Relationships of physical activity with metabolic syndrome features and low-grade inflammation in adolescents. Diabetologia (2006) 1.08
Loss of IL-15 receptor α alters the endurance, fatigability, and metabolic characteristics of mouse fast skeletal muscles. J Clin Invest (2011) 1.05
Sarcopenic obesity is closely associated with metabolic syndrome. Obes Res Clin Pract (2013) 1.04
Expression and function of myostatin in obesity, diabetes, and exercise adaptation. Med Sci Sports Exerc (2011) 1.03
Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways. Cell Mol Life Sci (2014) 1.03
Akt deficiency attenuates muscle size and function but not the response to ActRIIB inhibition. PLoS One (2010) 1.02
Muscle wasting in cancer. Int J Biochem Cell Biol (2013) 1.01
Irisin in response to exercise in humans with and without metabolic syndrome. J Clin Endocrinol Metab (2014) 1.00
Interleukin-15 and interleukin-15R alpha SNPs and associations with muscle, bone, and predictors of the metabolic syndrome. Cytokine (2008) 0.98
Increased energy expenditure and leptin sensitivity account for low fat mass in myostatin-deficient mice. Am J Physiol Endocrinol Metab (2011) 0.98
Interleukin-15 increases myosin accretion in human skeletal myogenic cultures. Cell Biol Int (2003) 0.98
Endurance training reduces the contraction-induced interleukin-6 mRNA expression in human skeletal muscle. Am J Physiol Endocrinol Metab (2004) 0.96
Constitutive and cytokine-induced production of interleukin-6 by human myoblasts. Immunol Lett (1994) 0.95
Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans. J Physiol (2003) 0.95
Normal Weight Obese syndrome: role of single nucleotide polymorphism of IL-1 5Ralpha and MTHFR 677C-->T genes in the relationship between body composition and resting metabolic rate. Eur Rev Med Pharmacol Sci (2006) 0.91
Systemic elevation of interleukin-15 in vivo promotes apoptosis in skeletal muscles of young adult and aged rats. Biochem Biophys Res Commun (2008) 0.91
Sarcopenia as a determinant of blood pressure in older Koreans: findings from the Korea National Health and Nutrition Examination Surveys (KNHANES) 2008-2010. PLoS One (2014) 0.88
Resistin in rodents and humans. Diabetes Metab J (2013) 1.03
Metformin and cancer in type 2 diabetes. Diabetes Metab J (2013) 0.81